NIH Director Jay Bhattacharya named John H. Powers III on Monday to permanently lead the National Institute of Allergy and Infectious Diseases as it shifts its research priorities away from biodefense.
Powers, the institute’s acting director and principal deputy director, will oversee its $6.56 billion annual budget and implement a recently released strategic plan. His background includes infectious-disease treatment and research on whether clinical trials measure outcomes that matter to patients.
NIAID was led by Anthony Fauci from 1984 until his retirement in December 2022.
The broader overhaul predates Monday’s appointment. NIH officials have described the institute’s priorities as infectious diseases currently affecting Americans and research into immunology, allergies and autoimmune diseases. They said Bhattacharya had worked to remove biodefense from NIH’s research portfolio because he considers it outside the agency’s mission.
Some infectious-disease researchers have warned that reducing that work could weaken pandemic preparedness. NIH’s appointment announcement nevertheless says NIAID will continue supporting research that helps respond to emerging public-health threats in the United States and abroad.

